BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18797198)

  • 1. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
    Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful alternative treatment containing vindesine for acute lymphoblastic leukemia with Charcot-Marie-Tooth disease.
    Ichikawa M; Suzuki D; Inamoto J; Ohshima J; Cho Y; Saitoh S; Kaneda M; Iguchi A; Ariga T
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):239-41. PubMed ID: 22246157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vincristine neurotoxicity in the presence of hereditary neuropathy.
    Trobaugh-Lotrario AD; Smith AA; Odom LF
    Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
    Tsurusawa M; Katano N; Hirota T; Ito M; Yanase T; Asami K; Koizumi S; Nakayama M; Miyawaki T; Suzumiya J; Nishikawa K; Mugisima H; Horikoshi Y; Hatae Y; Iwai A; Anami K; Kikuchi M; Osima K; Kaneko Y; Kataoka S; Tanaka A; Chin M; Taga T; Watanabe A; Fujimoto T
    Rinsho Ketsueki; 1998 Nov; 39(11):1092-8. PubMed ID: 9866420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor.
    Schiavetti A; Frascarelli M; Uccini S; Novelli A
    Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
    Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
    Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
    Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood.
    Pillon M; Aricò M; Basso G; Locatelli F; Citterio M; Micalizzi C; Testi AM; Barisone E; Nardi M; Lombardi A; Rondelli R; Rosolen A;
    Pediatr Blood Cancer; 2011 Apr; 56(4):544-50. PubMed ID: 21298738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe hemolysis and SIADH-like symptoms induced by vincristine in an ALL patient with liver cirrhosis].
    Nishihori Y; Yamauchi N; Kuribayashi K; Sato Y; Morii K; Hirayama Y; Sakamaki S; Honma H; Suzuki N; Kudo T; Niitsu Y
    Rinsho Ketsueki; 2000 Nov; 41(11):1231-7. PubMed ID: 11193445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute vincristine neurotoxicity in a non-Hodgkin's lymphoma patient with Charcot-Marie-Tooth disease].
    Uno S; Katayama K; Dobashi N; Hirano A; Ogihara A; Yamazaki H; Usui N; Kobayashi T; Inoue K; Kuraishi Y
    Rinsho Ketsueki; 1999 May; 40(5):414-9. PubMed ID: 10390891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute lymphoblastic leukemia in a patient with chronic cyanoacrylate exposure.
    Layden BT; Joseph M; Tallman MS; Platanias LC
    Acta Haematol; 2007; 118(4):242-3. PubMed ID: 18087146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
    Dunphy CH; Kitchen S; Saravia O; Velasquez WS
    Am J Hematol; 1996 Jan; 51(1):85-9. PubMed ID: 8571944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy.
    Ozyurek H; Turker H; Akbalik M; Bayrak AO; Ince H; Duru F
    Pediatr Hematol Oncol; 2007 Sep; 24(6):447-52. PubMed ID: 17710662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
    Crist W; Shuster J; Look T; Borowitz M; Behm F; Bowman P; Frankel L; Pullen J; Krance R; Steuber P
    Leukemia; 1992; 6 Suppl 2():162-6. PubMed ID: 1578922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The programmed therapy of acute lymphoblastic leukemia in adults].
    Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
    Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
    [No Abstract]   [Full Text] [Related]  

  • 18. Parotid acinar cell carcinoma in a long-term survivor of childhood acute lymphoblastic leukemia.
    Cheuk DK; Shek TW; Chan GC; Lau YL; Ha SY; Chiang AK
    Pediatr Blood Cancer; 2008 Mar; 50(3):636-9. PubMed ID: 16865683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
    Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosis.
    Gururangan S; Horner M; Rodman JH; Marina NM
    Med Pediatr Oncol; 1994; 22(6):414-6. PubMed ID: 8152404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.